Zobrazeno 1 - 10
of 162
pro vyhledávání: '"B, Metch"'
Autor:
G E, Gray, B, Metch, G, Churchyard, K, Mlisana, M, Nchabeleng, M, Allen, Z, Moodie, J, Kublin, L-G, Bekker, Elise, Levendal
Publikováno v:
Vaccine. 31(16)
Increased sexual risk behaviour in participants enrolled in HIV prevention trials has been a concern. The HVTN 503/Phambili study, a phase 2B study of the Merck Ad-5 multiclade HIV vaccine in South Africa, suspended enrollment and vaccinations follow
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 5(10)
As part of the multicenter Carotene and Retinol Efficacy Trial (CARET) lung cancer prevention study, we investigated the associations of baseline demographic, health history, and nutritional intake information and the prerandomization serum concentra
Autor:
William B. Farrar, B Metch, J P Minton, Saul E. Rivkin, Sylvan B. Green, Martin D. Abeloff, W R Jewell, A B Cruz, John J. Costanzi, C K Osborne
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 12(10)
PURPOSE To compare chemohormonal therapy, chemotherapy alone, and hormonal therapy alone in postmenopausal patients with estrogen receptor (ER)-positive operable breast cancer and positive axillary nodes with respect to survival and disease-free surv
Publikováno v:
Oncology nursing forum. 20(9)
There is increasing interest in evaluating the impact of cancer treatment and medical intervention on patient quality of life (QOL). This article reports the findings of a substudy that incorporated the Functional Living Index--Cancer in an ongoing a
Autor:
C K Osborne, John J. Costanzi, B Metch, Sylvan B. Green, O'Bryan Rm, Saul E. Rivkin, W R Jewell, S J Altman, J P Minton
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(9)
PURPOSE To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide, methotrexate, fluorouracil [5-FU], vincristine, and prednisone [CMFVP]) in poor-prognosis breast cancer patients (estrogen recept
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2(4)
In preparation for a phase IV lung cancer chemoprevention trial, we conducted a pilot trial of beta-carotene and retinol in high-risk smokers. Eligibility criteria were ages of 50-69 years, a smoking history of at least 20 pack-years, and either bein
Autor:
G S, Omenn, G E, Goodman, M D, Thornquist, L, Rosenstock, S, Barnhart, I, Gylys-Colwell, B, Metch, B, Lund
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2(4)
Pilot studies are an essential component for major chemoprevention trials. Prior to initiating the multicenter Carotene and Retinol Efficacy Trial to assess the effectiveness of beta-carotene and retinol for preventing lung cancer, we conducted pilot
Publikováno v:
Cancer chemotherapy and pharmacology. 31
The Southwest Oncology Group (SWOG) performed a phase II trial of a combination of ifosfamide/mesna/cisplatin in patients with metastatic soft-tissue sarcoma who had previously received one chemotherapeutic regimen. A total of 39 patients were regist
Publikováno v:
Cancer. 70(10)
Malignant mesothelioma is a highly treatment-resistant neoplasm. This study represents an attempt to define an effective form of systemic therapy.Twenty-six patients with unresectable diffuse malignant mesothelioma were enrolled in Southwest Oncology
Publikováno v:
Oncology (Williston Park, N.Y.). 4(5)
The Southwest Oncology Group Quality of Life Questionnaire is based on six policy recommendations adopted by the Group: 1. Always measure physical functioning, emotional functioning, symptoms, and global quality of life separately. 2. Include measure